Acute Kidney Injury Clinical Trial
Official title:
Goal Directed Therapy in Septic Shock - the Effects of Mean Arterial Pressure Levels, Adjusted With Norepinephrine, on Renal Perfusion, Function and Oxygenation.
The purpose of this study is to evaluate renal effects of 3 different levels of mean arterial pressure in early case of septic shock. In 8 patients diagnosed with early septic shock, we will adjust mean arterial pressure (MAP) to three different levels, using norepinephrine. At each level of MAP, central and renal hemodynamics and oxygenation states will be measured. Analysis will be made to describe the pathophysiology at MAP 75 mmHg, and then to evaluate at which MAP renal function and oxygenation is least affected negatively.
It is under debate what level of mean arterial pressure is the most appropriate for organ
perfusion in septic shock. The kidneys are usually used for end-organ evaluation of
appropriate perfusion and appropriate blood pressure level. What "adequate blood pressure"
means is today unclear.
The purpose of this study is to chart the renal perfusion, oxygenation and function, and
moreover to evaluate renal effects of 3 different levels of mean arterial pressure, in early
phase of septic shock.
Patients will be included within the first 24 hrs after admission to the ICU diagnosed with
septic shock. The patients will be sedated, mechanically ventilated and in need for
norepinephrine for adequate blood pressure levels.
After 60 mins of steady state at MAP 75 mmHg, norepinephrine will be adjusted achieve MAP of
60 and 90 mmHg respectively, MAP being held at each level for 30 mins. At the end of each 30
mins period, central and renal hemodynamics will be measured, blood and urine samples will
be collected.
Central hemodynamics will be measured by, and blood samples collected via a pulmonary
catheter and an arterial line.
Renal hemodynamics will be measured using a renal vein catheter for retrograde
thermodilution giving at hand renal blood flow (RBF), renal vein blood samples and urine
collection provides extraction of Cr-EDTA for filtration fraction (FF) and glomerular
filtration rate (GFR), renal oxygen consumption, and renal oxygen extraction as a measure of
balance between renal oxygen delivery and consumption.
Via renal vein catheterisation and retrograde thermodilution, the study group have the
unique possibility to actually evaluate renal blood flow, renal oxygenation and renal
function in humans in vivo.
After finishing the data collection, analysis will be made to answer the question: which MAP
is the most optimal concerning RBF, GFR and renal oxygenation in patients with septic shock?
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05538351 -
A Study to Support the Development of the Enhanced Fluid Assessment Tool for Patients With Acute Kidney Injury
|
||
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03938038 -
Guidance of Ultrasound in Intensive Care to Direct Euvolemia
|
N/A | |
Recruiting |
NCT05805709 -
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
|
N/A | |
Recruiting |
NCT05318196 -
Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
|
||
Recruiting |
NCT05897840 -
Continuous Central Venous Oxygen Saturation Measurement as a Tool to Predict Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04986137 -
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
|
||
Terminated |
NCT04293744 -
Acute Kidney Injury After Cardiac Surgery
|
N/A | |
Completed |
NCT04095143 -
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
|
||
Not yet recruiting |
NCT06026592 -
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
|
||
Not yet recruiting |
NCT06064305 -
Transcriptional and Proteomic Analysis of Acute Kidney Injury
|
||
Terminated |
NCT03438877 -
Intensive Versus Regular Dosage For PD In AKI.
|
N/A | |
Terminated |
NCT03305549 -
Recovery After Dialysis-Requiring Acute Kidney Injury
|
N/A | |
Completed |
NCT05990660 -
Renal Assist Device (RAD) for Patients With Renal Insufficiency Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT04062994 -
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
|
||
Terminated |
NCT02860130 -
Clinical Evaluation of Use of Prismocitrate 18 in Patients Undergoing Acute Continuous Renal Replacement Therapy (CRRT)
|
Phase 3 | |
Completed |
NCT06000098 -
Consol Time and Acute Kidney Injury in Robotic-assisted Prostatectomy
|
||
Not yet recruiting |
NCT05548725 -
Relation Between Acute Kidney Injury and Mineral Bone Disease
|
||
Completed |
NCT02665377 -
Prevention of Akute Kidney Injury, Hearttransplant, ANP
|
Phase 3 | |
Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A |